Bio-Rad Laboratories BIO
NYSE BIO
$376.85 -3.27 (-0.86%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) Net Margin Growth (5y) (2014 - 2026)

Analysis

Bio-Rad Laboratories (BIO) Net Margin Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 225.48 Bn 221.41 Bn 8.34 Bn
2 Danaher 144.42 Bn 140.08 Bn 3.61 Bn
3 Agilent Technologies 40.86 Bn 39.11 Bn 1.04 Bn
4 Illumina 30.97 Bn 29.80 Bn 770.00 Mn
5 Revvity 13.85 Bn 12.83 Bn 416.87 Mn
6 Bio-Techne 11.27 Bn 11.01 Bn 211.39 Mn
7 Bio-Rad Laboratories 10.11 Bn 8.49 Bn 345.80 Mn
8 Repligen 9.33 Bn 8.31 Bn 110.04 Mn
9 10x Genomics 8.77 Bn 8.21 Bn 112.50 Mn
10 Bruker 8.30 Bn 8.09 Bn 416.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -7,064.00
Mar 31, 2026 -22,350.00
Dec 31, 2025 -338.00
Sep 30, 2025 -25,549.00
Jun 30, 2025 -13,123.00
Mar 31, 2025 -10,907.00
Dec 31, 2024 -19,586.00
Sep 30, 2024 14,671.00
Jun 30, 2024 -44,373.00
Mar 31, 2024 -9,333.00
Dec 31, 2023 18,564.00
Sep 30, 2023 -3,260.00
Jun 30, 2023 -21,719.00
Mar 31, 2023 -10,890.00
Dec 31, 2022 10,004.00
Sep 30, 2022 -2,805.00
Jun 30, 2022 -13,486.00
Mar 31, 2022 -48,346.00
Dec 31, 2021 -21,034.00
Sep 30, 2021 52,248.00